NORTH PALM BEACH, FL / ACCESSWIRE / March 19, 2024 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent", or the "Company"), a clinical-stage biotechnology Company developing monoclonal antibodies targeting various cancer types, and HypoSpray Pharma ("HypoSpray®"), a clinical and commercial stage drug delivery technology company, announced today a collaboration to develop an alternative delivery... Read more
New Investment and Partnership Platform Will Accelerate Next Generation Ag-tech Innovation INDIANAPOLIS, March 19, 2024 /PRNewswire/ -- Corteva, Inc. (NYSE: CTVA) today announced the launch of Corteva Catalyst, a new investment and partnership platform focused on accessing and bringing to market agricultural innovations that advance the company's R&D priorities and drive value creation. Corteva... Read more
MENLO PARK, Calif., March 19, 2024 /PRNewswire/ -- Cyngn Inc. (the "Company" or "Cyngn") (Nasdaq: CYN), a developer of AI-powered autonomous driving solutions for industrial applications today announced its initial DriveMod Tugger deployment with Rivian, the innovative leading electric vehicle manufacturer. The deployment was at Rivian's Normal, IL manufacturing facility. This deployment continues to... Read more
SAN DIEGO, March 19, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the publication of a study of optical genome mapping (OGM) in hereditary breast and ovarian cancer (HBOC) syndrome showing that when tumors exhibited higher overall numbers of structural variations (SVs) they tended to have more mutated genes and altered signaling pathways, which may correlate with poor... Read more
Zembrace® SymTouch® and Tosymra® will be marketed by Tonix Medicines, Tonix’s wholly-owned commercial subsidiary Commercial capabilities prepare Tonix for the potential launch in 2025 of Tonmya™ for the management of fibromyalgia, assuming FDA approval CHATHAM, N.J., March 19, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a biopharmaceutical company with... Read more
TORONTO, March 19, 2024 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, announced today that the FDA advised the Company to submit a Type C meeting request to discuss evaluating a proposed Phase 2 clinical study of... Read more
A Novel Approach to Combatting Binge Behaviors with Groundbreaking Psychedelic Therapy Tel Aviv, Israel / Vancouver, Canada, March 19, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY) (“Clearmind” or the "company"), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, announced that it has been... Read more
Research institutions in the United States, Canada, Israel, and Belgium, including Johns Hopkins University, will study PEX010, Filament's botanical psilocybin drug candidate VANCOUVER, BC, March 19, 2024 /CNW/ - Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical‐stage natural psychedelic drug development company, announced that since March 1, 2024 it has... Read more
CALGARY, Alberta, March 19, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANUA WKN: A3UNZ), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased to provide a summary of Company’s achievements in 2023 and objectives planned for 2024. Dr. Allen Davidoff, CEO of... Read more
Second biotechnology company to potentially out-license novel compounds from Enveric’s portfolio of assets with possible significant milestone payments and royalties CAMBRIDGE, Mass. / Mar 19, 2024 / Business Wire / Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of... Read more
Collaboration will help automation customers create factories of the future MILWAUKEE / Mar 18, 2024 / Business Wire / Rockwell Automation (NYSE:ROK), the world’s largest company dedicated to industrial automation and digital transformation, today announced it is collaborating with NVIDIA to accelerate a next-generation industrial architecture. Manufacturing is a $15-trillion global industry that touches... Read more
Solution combines SoundHound Chat AI with a large language model running in-vehicle on NVIDIA DRIVE for seamless voice interaction SANTA CLARA, Calif. / Mar 18, 2024 / Business Wire / SoundHound AI, Inc. (Nasdaq: SOUN), a global leader in voice artificial intelligence, today announced an innovative in-vehicle voice assistant that uses a large language model (LLM) completely on the edge while running on the... Read more
HOLLYWOOD, Fla., March 18, 2024 (GLOBE NEWSWIRE) -- NV5 Global, Inc. (the “Company” or “NV5”) (Nasdaq: NVEE), a provider of technology, conformity assessment, and consulting solutions, announced today that it has been awarded a three-year, $27 million contract by the California Department of Transportation (Caltrans) District 6 to provide construction management for not at-risk services. NV5 will deliver... Read more
MALMÖ, Sweden, March 18, 2024 (GLOBE NEWSWIRE) -- Oatly Group AB (Nasdaq: OTLY)(“Oatly” or the “Company”), the world’s original and largest oatmilk company, kicked off a marketing partnership with global fitness brand Barry’s today, bringing the Company’s new Unsweetened Oatmilk to Fuel Bar menus in Barry’s studios nationwide. Barry’s Fuel Bars provide clients with pre-and-post workout shakes that aid in their... Read more
NEW YORK, March 18, 2024 /CNW/ - Galaxy Digital Holdings Ltd. (TSX: GLXY) ("Galaxy") announced that its affiliate, Galaxy Asset Management, ("GAM"), reported preliminary assets under management of $10.1 billion as of February 29, 2024. The 24.8% increase in preliminary AUM compared to the prior month was primarily driven by market appreciation, partially offset by net outflows associated with an ongoing... Read more
Singapore, March 18, 2024 (GLOBE NEWSWIRE) -- Bitdeer Technologies Group (NASDAQ: BTDR), a leading provider of blockchain and high-performance computing solutions, announced today that it has completed the deployment and successful testing of its NVIDIA DGX SuperPOD H100 system ahead of schedule, becoming the first cloud service platform in the Asian region to offer NVIDIA DGX SuperPOD H100 service. “We are... Read more
Launch of 1Valour STOXX Bitcoin Suisse Digital Asset Blue Chip ETP: DeFi Technologies Inc. announces a collaborative product from Valour Inc., Bitcoin Suisse AG, and STOXX, offering a diversified investment in top blue-chip digital assets through a new Exchange Traded Product (ETP). Innovative Methodology and Partnerships: The ETP, tracking the STOXX Digital Asset Blue Chip X Index, is based on a rule-based... Read more
NEW YORK, March 18, 2024 /PRNewswire/ -- Bit Digital, Inc. (Nasdaq: BTBT) (the "Company"), a sustainable platform for digital assets and artificial intelligence ("AI") infrastructure headquartered in New York City, announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2023 with the U.S. Securities and Exchange Commission ("SEC") on March 18, 2024. Financial Highlights... Read more
First patient screened ahead of schedule Trial to investigate positive, negative, and cognitive domains of schizophrenia ANAVEX®3-71’s differentiated dual novel mechanism of action offers the potential to synergistically activate both SIGMAR1 and M1 muscarinic receptors and treat all symptom domains of schizophrenia without the side effects of standard of care antipsychotics NEW YORK, March 18, 2024 (GLOBE... Read more
TN-401 AAV9-Based Gene Therapy Being Developed to Treat the Underlying Cause of PKP2-associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) PKP2 Gene Replacement Therapy Normalized Heart Rhythms, Reversed Disease Progression and Extended Survival in a Severe Mouse Model of Disease Tenaya Anticipates Dosing First Patient in Phase 1b RIDGE™-1 Clinical Trial of TN-401 in Second Half of 2024 SOUTH SAN... Read more
Significant increase in number of points of sale (100%) for Happy Caps Mushroom Home Grow Kits Toronto, Ontario--(Newsfile Corp. - March 18, 2024) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), a company engaged in the production, growth and sale of functional mushrooms and mushroom home grow kits in North America and Europe and a premium brand of... Read more
Initial Data from Ongoing MyPeak™-1 Phase 1b of TN-201 for MYBPC3-associated HCM Expected in Second Half of 2024 On Track to Dose First Patient in RIDGE™-1Phase 1b Clinical Trial of TN-401 for PKP2-associated ARVC in Second Half 2024 $47 Million Net Proceeds from Recent Financing Extends Cash Runway into Second Half of 2025 SOUTH SAN FRANCISCO, Calif., March 18, 2024 (GLOBE NEWSWIRE) -- Tenaya Therapeutics,... Read more
SAN DIEGO, March 18, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, today highlighted recent corporate achievements and reported financial results for the fourth quarter and full year ended December 31, 2023. “We ended 2023 on a strong note, shipping our... Read more
Revenue of $52.3 million, down from $60.6 million in the same quarter a year ago, and up 22% sequentially over the prior quarter Year-over-year improvements to net loss, adjusted EBITDA, gross margins, non-GAAP gross margins, operating expenses, and operating cash flow following more than $150 million in cost reduction efforts announced since June 2022 Net loss of $(323.4) million in 2023 compared to net loss of... Read more
Technology Innovator Unveils Future Concepts for K1 Super Tower, K10 Patrol and K15 Tactical MOUNTAIN VIEW, Calif. / Mar 15, 2024 / Business Wire / Knightscope, Inc. [Nasdaq: KSCP] (“Knightscope” or the “Company”), a leading innovator in robotics and artificial intelligence (“AI”) technologies focused on public safety, announced on March 14, 2024 that, based on management’s estimates, its unaudited revenues for... Read more
Toronto, Ontario--(Newsfile Corp. - March 15, 2024) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: VGANF) ("Happy Belly" or the "Company"), a leading consolidator of emerging food brands is pleased to announce the opening of its newest Heal Wellness location on Queen Street East in The Beaches neighborhood in Toronto, Ontario."Serving up fresh smoothie bowls, acai bowls, and smoothies in our newest location is... Read more
Divestiture Reflects Strategy to Focus on Strategic HPC Sites in North Dakota Redirects Resources and Strengthens Balance Sheet DALLAS, March 15, 2024 (GLOBE NEWSWIRE) -- Applied Digital Corporation (Nasdaq: APLD) ("Applied Digital" or the "Company"), a designer, builder, and operator of next-generation digital infrastructure designed for High-Performance Computing (“HPC”) applications, today announced that... Read more
All Cash Acquisition To Increase Marathon’s Bitcoin Mining Portfolio to 1.1 Gigawatts, 54% of which Will Reside on Sites Directly Owned and Operated by the Company Fort Lauderdale, FL, March 15, 2024 (GLOBE NEWSWIRE) -- Marathon Digital Holdings, Inc. (NASDAQ:MARA) ("Marathon" or "Company"), one of the world’s largest publicly traded Bitcoin miners and a leader in supporting and securing the Bitcoin ecosystem,... Read more
Anxiety disorders are the most prevalent mental health disorders globally1, contributing to over 28 million disability-adjusted life years (“DALYs”)2 Highly scalable intermittent treatment for Generalized Anxiety Disorder (“GAD”) with an expected treatment time of approximately 90-minutes from a single administration Proprietary deuterated dimethyltryptamine (“DMT”) molecule with U.S. composition of... Read more
Corporate Update Call to be Held Thursday, March 21, 2024 at 11:00am ET to Discuss Recent FDA Breakthrough Therapy Designation and Phase 3 Clinical Plans SAN DIEGO, CA / ACCESSWIRE / March 15, 2024 / Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC), a clinical-stage company applying transformative chemistry to improve prescription drug safety, today reported financial results for the fourth... Read more
SUNNYVALE, Calif., March 14, 2024 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced today that the U.S. Food and Drug Administration (FDA) provided 510(k) clearance for da Vinci 5, the company’s next-generation multiport robotic system. “We are pleased to receive FDA clearance for our fifth-generation robotic... Read more
HOLLYWOOD, Fla., March 14, 2024 (GLOBE NEWSWIRE) -- NV5 Global, Inc. (the “Company” or “NV5”) (Nasdaq: NVEE), a provider of technology, conformity assessment, and consulting solutions, announced today that it has acquired Fluhrer Reed, a provider of structural engineering and forensics engineering services in the Research Triangle of North Carolina, one of the nation’s fastest growing markets. Founded in 1999,... Read more
MENLO PARK, Calif., March 14, 2024 /PRNewswire/ -- Cyngn Inc. (the "Company" or "Cyngn") (Nasdaq: CYN) today announced its strategic partnership with RobotLAB, a premier robotics integrator that has deployed over 10,000 robots with customers across the globe. As a part of this partnership, RobotLAB will purchase ten fully-autonomous DriveMod Tuggers from Cyngn to establish an initial fleet for sale to end... Read more
Pulp sustainable gourmet USDA Organic fermented sauces BELVIDERE, NJ, March 14, 2024 (GLOBE NEWSWIRE) -- Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leader in controlled environment agriculture (CEA), locally grown, organic and sustainable produce and products, today announced at Natural Products EXPO WEST® 2024 that KeHE Distributors will carry Edible Garden’s new... Read more
The Company fully retired its senior convertible debt in February 2024 after paying down approximately 50 percent in November 2023. The Company ended the year with $48.9 million in cash and marketable securities. Reported revenues increased 24 percent to $473.3 million. Reported gross profit increased $20.1 million to $23.6 million. Net loss from continuing operations, net of income taxes, was $111.3 million... Read more
Moka.ai focuses on behavioral science and a proven long-term investing strategy Disruptive, flat-fee monthly subscription model Innovative, patent-pending wealth calculator VANCOUVER, British Columbia / Mar 14, 2024 / Business Wire / Mogo Inc. (NASDAQ:MOGO) (TSX:MOGO), a digital wealth and payments business, announced the launch of Moka.ai, the next generation of its wealth-building app with significant... Read more
The 50 MW Data Center Clears the Modeling Phase in the ERCOT Process ALBANY, N.Y. / Mar 14, 2024 / Business Wire / Soluna Holdings, Inc. (“SHI” or the “Company”), (NASDAQ: SLNH), a developer of green data centers for intensive computing applications including Bitcoin mining and AI, announced today Project Dorothy 2, its 50 MW data center co-located at a wind farm in Texas, has passed the modeling phase in the... Read more
SHENZHEN, China, March 14, 2024 (GLOBE NEWSWIRE) -- Xunlei Limited (“Xunlei” or the “Company”) (NASDAQ: XNET), a leading technology company providing distributed cloud services in China, today announced its unaudited financial results for the fourth quarter and full year ended December 31, 2023. Fourth Quarter 2023 Financial Highlights: Total revenues were US$77.1 million, a decrease of 20.4%... Read more
33% Response Rate and 100% Disease Control Rate Observed in Patients Evaluated for Efficacy Complete Response of Non-Target Tumor Also Observed Platinum-Resistant Ovarian Cancer is a Devastating Serious Condition of Unmet Medical Need with a Median Life Expectancy of Approximately One Year Fort Lee, NJ, March 14, 2024 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) today announced preliminary data... Read more
NUV-1511 is the Company’s first drug-drug conjugate (DDC) to enter the clinic NEW YORK / Mar 14, 2024 / Business Wire / Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today announced that the first patient has been dosed in a Phase 1/2 study of NUV-1511, the Company’s first DDC to... Read more
IMM-1-104 has been well-tolerated, demonstrating the potential for a differentiated safety profile 100% suppression of acquired RAS alterations was observed in evaluable patients profiled for ctDNA and treated with IMM-1-104, supporting goal of Universal-RAS activity Target lesion regression observed in over half of patients treated with IMM-1-104 at 320mg or 240mg QD, with best individual lesion... Read more
HAIFA, Israel, March 14, 2024 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq:PLUR) (TASE:PLUR) ("Pluri" or "the Company"), a leading biotechnology company that transforms cells into solutions, today announced that its CDMO division (PluriCDMO™) has signed a manufacturing agreement with Remedy Cell Ltd, an innovative, biopharmaceutical company developing stem cell-derived, cell-free therapeutics for complex fibrotic... Read more
With U.S. Food and Drug Administration (“FDA”) alignment on multisite, multinational Phase 3 program design Company expects to commence Phase 3 program around mid-year 2024 15 U.S. clinical trials sites targeted; European sites to be added Robust and sustained improvement in depression symptoms with CYB003 at four months with 75% of patients in remission from depression after two doses... Read more
ANN ARBOR, MI / ACCESSWIRE / March 14, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, today announced the publication of a peer-reviewed research study favorably comparing the capabilities for the diagnosis of feline hyperthyroidism of its novel, point-of-care TRUFORMA... Read more
Interim data from initial dose escalation cohorts from Phase 1 trial of TERN-701 (allosteric BCR-ABL) for treatment of CML expected in second half of 2024 Top-line data from Phase 1 trial of TERN-601 (oral GLP-1) for obesity expected in second half of 2024 Cash, cash equivalents and marketable securities of $263 million, expected to provide runway into 2026 FOSTER CITY, Calif., March 14, 2024 (GLOBE... Read more
Reported the First-Ever Durable Persistence of an Allogeneic Cellular Therapy from a Phase 1 Study of INB-100 in Leukemia where 100% of Evaluable Patients (n=10) Treated Remained in Remission, including six Patients Alive and Progression Free Past 12 Months Presented Positive Results from a Phase 1 Study in Newly Diagnosed Glioblastoma (GBM) Demonstrating All Patients Treated with INB-200 Exceeded... Read more
IPA reports a fourth consecutive quarter of increased revenue. VICTORIA, British Columbia / Mar 14, 2024 / Business Wire / IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA), an artificial intelligence-driven biotherapeutic research and technology company, today reported financial results for its third quarter of the 2024 fiscal year (“FY24”), which ended January 31, 2024. “ImmunoPrecise... Read more
Q1-24 revenues of $13.5 million, up 3% over Q1-23 Q1-24 adjusted EBITDA loss of $2.1 million compared to $2.2 million for Q1-23, down 6% Total Enerzair and Atectura prescriptions for the 12 months ending January 31, 2024, exceeded 78,000, up 130% over the 12 months ending January 31, 2023 MONTREAL, March 14, 2024 /CNW/ - Valeo Pharma Inc. (TSX: VPH) (OTCQB: VPHIF) (FSE: VP2) ("Valeo" or the "Company"), a... Read more
ORLANDO, FL / ACCESSWIRE / March 13, 2024 / PureCycle Technologies, Inc. (NASDAQ:PCT) and Churchill Container, today, announced the successful manufacturing of a polypropylene cup made with 50% PureCycle resin. Churchill Container produces rigid plastic cups for clients in the sports, theater and restaurant industries. PureCycle CEO Dustin Olson said, "This is a glimpse into the future of circularity. This is what... Read more
Church & Dwight partners with Rockwell Automation to uplevel OT cybersecurity program, implementing rigorous security standards MILWAUKEE / Mar 13, 2024 / Business Wire / Rockwell Automation Inc. (NYSE: ROK), the world’s largest company dedicated to industrial automation and digital transformation, today announced it has been selected by Church & Dwight Co., Inc. (NYSE: CHD) to strengthen the consumer... Read more
TAMPA BAY, FL / ACCESSWIRE / March 13, 2024 / Atlantic Power & Infrastructure Corp. (OTC PINK:AWSL) continues to lead the industry with its proprietary Flexi®-Pave technology. The management at ‘Estates at Carpenters' in Lakeland, Florida, has chosen Flexi®-Pave as the ultimate solution for their safety, stormwater management, and aesthetic needs. Elevating Safety and AestheticsThe ‘Estates at Carpenters'... Read more
Company Receives First Purchase Order for Newly Announced Access Control Solution Detroit, Michigan, March 13, 2024 (GLOBE NEWSWIRE) -- Robotic Assistance Devices (RAD), a subsidiary of Artificial Intelligence Technology Solutions, Inc. (the “Company”) (OTCPK:AITX), today announced it received the first order for a solar-powered AVA™ autonomous access control device. The end user is in the Oil & Gas... Read more
Highlights: The Pulse Guru: A smart sensor wearable that redefines access to signal data for vital cardiovascular insights. Designed for healthcare innovators, researchers, and others in need of essential "raw" signal capture. The Pulse Guru's continuous stream of rich time-series data is not accessible from mainstream smartwatches such as Apple, Google, Garmin, or Fitbit. VICTORIA, BC / ACCESSWIRE / March... Read more
VANCOUVER, BC, March 13, 2024 /CNW/ - Generative AI Solutions Corp. ("GenAI" or the "Company") (CSE: AICO) (OTCQB: AICOF) is pleased to announce that its wholly-owned subsidiary, MAI Cloud Solutions Inc. ("MAI Cloud"), has entered into a framework services agreement dated March 7, 2024 (the "Services Agreement") with a Cloud, GPU ("Graphics Processing Unit") and AI Infrastructure services provider (the... Read more
Fourth Quarter Highlights Record quarterly revenue of $405 million increases 31 percent year-over-year ARR of $1.464 billion increases 22 percent year-over-year Achieves first quarter of GAAP profitability as a public company Cash flow from operations and non-GAAP adjusted free cash flow reach $146 million NEW YORK / Mar 13, 2024 / Business Wire / UiPath, Inc. (NYSE: PATH), a leading enterprise automation... Read more
Announced Transaction to Acquire Additional 900 MHz Spectrum Licenses Mariam Sorond Joins as NextNav CEO MCLEAN, Va., March 13, 2024 (GLOBE NEWSWIRE) -- NextNav Inc. (NASDAQ: NN) (“NextNav” or the “Company”) a leader in next generation positioning, navigation, and timing (PNT) and 3D geolocation, today reported financial results for NextNav’s fourth quarter and full year ended December 31, 2023. Mariam... Read more
ATLANTA, March 13, 2024 (GLOBE NEWSWIRE) -- Perma-Fix Environmental Services, Inc. (NASDAQ: PESI) (the “Company”) today announced financial results and provided a business update for the fourth quarter and full year ended December 31, 2023. Mark Duff, President and CEO of the Company, commented, “I am pleased to report solid financial results for the fourth quarter and 2023. Specifically, we achieved a 35.6% and... Read more
LUXEMBOURG / ACCESSWIRE / March 13, 2024 / Moolec Science SA (NASDAQ:MLEC) a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming technology, announced today its Business Update for the second quarter of Fiscal Year 2024 ended December 31, 2023. The main highlights of Moolec's business update are as follows: SOOY1 | Piggy Sooy™ Platform: Third generation... Read more
LOS ANGELES, CA / ACCESSWIRE / March 13, 2024 / Crown Electrokinetics Corp. (NASDAQ:CRKN) ("Crown" or the "Company"), a leading smart glass technology company and an expert in constructing fiber optic networks, today provided financial guidance for its fiscal first and second quarter of 2024. Doug Croxall, CEO of Crown said, "We are excited to be providing the Company's first quarterly revenue and earnings... Read more
VANCOUVER, British Columbia, March 13, 2024 (GLOBE NEWSWIRE) -- BIGG Digital Assets Inc. (“BIGG” or the “Company”) (CSE: BIGG; OTCQX: BBKCF; WKN: A2PS9W), a leading innovator in the digital assets space and owner of Netcoins, and Blockchain Intelligence Group and TerraZero is pleased to report that Netcoins USA Inc has entered into a partnership with Zero Hash, a global leading Crypto infrastructure provider to... Read more
COPYRIGHT ©2022 GREEN STOCK NEWS